Multiple studies have shown that in SARS-CoV-2 patients with cardiovascular disease, elevated markers of thrombo-inflammatory activation like CRP, IL-6, and troponins are predictors of mortality (25). The gene discussed is IL6; the disease is cardiovascular disorder.